Preoperative prostate needle biopsy p27 correlates with subsequent radical prostatectomy p27, gleason grade and pathological stage

Journal of Urology

Volumn 164, Issue 6, 2000, Pages 1987-1991

  Thomas, George V ^a   Schrage, Matthew I ^a   Rosenfelt, Lisa ^a   Kim, Jin Hee ^a   Salur, Giri ^a   DeKernion, Jean B ^a   Dorey, Frederick ^a   Said, Jonathan ^a   Reiter, Robert E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biopsy; Genes; Prostatectomy; Prostatic neoplasms; Suppressor; Tumor

Indexed keywords

PROTEIN P27;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATECTOMY; PROTEIN EXPRESSION; SURGICAL TECHNIQUE; TUMOR SUPPRESSOR GENE; VALIDATION PROCESS;

EID: 0033767353     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66934-0     Document Type: Article

References (14)

1. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer
2. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control
3. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals
4. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients
5. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
6. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
7. Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
8. Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma
9. Expression of p27kip1 in prostatic adenocarcinoma
10. Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
11. Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma
12. Low p27 expression predicts poor disease-free survival in patients with prostate cancer
13. p53 and bcl-2 immunohistochemistry in pretreatment prostate needle biopsies to predict recurrence of prostate cancer after radical prostatectomy
14. Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy